| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.28 | 2e-08 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |